Advertisement

Topics

Global Interleukin-6 (IL-6) Inhibitors Therapeutics Pipeline Analysis Report 2017 – ResearchAndMarkets.com

17:04 EDT 15 Mar 2018 | Biotech 365

DUBLIN–(BUSINESS WIRE)–The “Interleukin-6 (IL-6) Inhibitors Therapeutics Pipeline Analysis, 2017 – Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments” report has been added to ResearchAndMarkets.com’s offering. The study analyzed that the IL-6 inhibitors therapeutics pipeline comprises approximately 18 active … Continue reading

Cet article Global Interleukin-6 (IL-6) Inhibitors Therapeutics Pipeline Analysis Report 2017 – ResearchAndMarkets.com est apparu en premier sur Biotech 365.

Original Article: Global Interleukin-6 (IL-6) Inhibitors Therapeutics Pipeline Analysis Report 2017 – ResearchAndMarkets.com

NEXT ARTICLE

More From BioPortfolio on "Global Interleukin-6 (IL-6) Inhibitors Therapeutics Pipeline Analysis Report 2017 – ResearchAndMarkets.com"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...